ABBY GOERGEN: Open Payments
NPI 1851736060 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 25 payments from 8 companies in 2025. Trend: 2023 $323 · 2024 $947 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $170 |
| UCB, Inc. | 3 | $161 |
| Novartis Pharmaceuticals Corporation | 9 | $160 |
| GENZYME CORPORATION | 1 | $121 |
| Janssen Biotech, Inc. | 3 | $114 |
| Organon LLC | 1 | $92 |
| ABBVIE INC. | 3 | $62 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: OPZELURA, DUPIXENT, TREMFYA, VTAMA, SKYRIZI, COSENTYX, Rhapsido, Bimzelx.
Industry payments across NY — which companies pay providers there.
